Rowad Engineering signs contract with EIPICO worth EGP 418m
The company added that the total project value amounts to EGP 418m and that the the contract will be implemented over a 13-month period starting from the signing date on a turnkey basis.
Latest in Tag: EIPICO Highlight
Latest in Tag: EIPICO
EIPICO obtains EDA approval to produce anti-COVID drug before mid-January 2022
EIPICO explained that manufacturing will commence under the supervision of the EDA, noting that production of Covapravir will take place using the unutilised capacities of the company.
EIPICO targets 2023 start of Biosimilar Project with EGP 400-600m revenues in 1st year
Local market size for oncology and hormone-based products is estimated at EGP1.5bn, which is currently 100% imported
EIPICO, Reliance Life Science sign agreement to produce biologic drugs
EIPICO produces 18% of antibiotics available in Egyptian market
Medical Union Pharmaceuticals targets 16% sales growth to EGP 2.9bn in 2021
Company plans to inaugurate three production lines in Q1 of 2021
EIPICO eyes EGP 800m investments over 3 years, excluding biosimilar project
A source has revealed that the Egyptian pharmaceutical company, EIPICO, plans to invest about EGP 800m over the next three years, directed towards re-modelling and renewing the machinery at its facilities. The financing will not be directed to its biosimilar project.
EIPICO to export 100,000 Remdesivir vials to 11 countries
The countries that will receive the Egyptian manufactured vaccine are Russia, Ukraine, Kazakhstan, Uzbekistan, Moldova, Belarus, Kurdistan, Tajikistan, Poland, the Czech Republic, and Slovakia.
EIPICO reports 17% y-o-y revenues decline to EGP 1.46bn in H1 2020
Pharmaceutical company underperformed on market, reporting aggressive 31% decline in retail sales
EIPICO begins production of COVID-19 drug approved by Russia, China
The production of the drug comes after EIPICO received approval from the Egyptian Drug Authority (EDA).
EIPICO reports lower production, EGP 93m losses due to COVID-19
Company’s operations suffered from traffic disruption, interruption of shipping and export operations
EIPICO starts acquisition measures of 9.77% stake of MUP for over EGP 200m
New financial adviser appointed to assess fair value of deal before sending required documents to FRA
EIPICO postpones development plans due to US dollar shortage
The delayed development plans include recently announced new activities due to directing the dollar’s resources to the import of raw materials, says head of financial division